Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
From MaRDI portal
Cites work
- \(p\)-values for high-dimensional regression
- Q- and A-learning methods for estimating optimal dynamic treatment regimes
- A lasso for hierarchical interactions
- A PRIM approach to predictive-signature development for patient stratification
- A regression tree approach to identifying subgroups with differential treatment effects
- A robust method for estimating optimal treatment regimes
- A significance test for the lasso
- A simple method for estimating interactions between a treatment and a large number of covariates
- A weakly informative default prior distribution for logistic and other regression models
- Additive logistic regression: a statistical view of boosting. (With discussion and a rejoinder by the authors)
- Analysis of randomized comparative clinical trial data for personalized treatment selections
- Assessing treatment-selection markers using a potential outcomes framework
- BART: Bayesian additive regression trees
- Bayesian Subset Analysis
- Combining biomarkers to optimize patient treatment recommendations
- Effectively Selecting a Target Population for a Future Comparative Study
- Estimating individualized treatment rules using outcome weighted learning
- Estimating optimal treatment regimes from a classification perspective
- Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies
- Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
- Estimating treatment effect heterogeneity in randomized program evaluation
- Evaluating Markers for Selecting a Patient's Treatment
- Greedy function approximation: A gradient boosting machine.
- scientific article; zbMATH DE number 5957245 (Why is no real title available?)
- scientific article; zbMATH DE number 3860199 (Why is no real title available?)
- scientific article; zbMATH DE number 45848 (Why is no real title available?)
- scientific article; zbMATH DE number 1089157 (Why is no real title available?)
- scientific article; zbMATH DE number 1779487 (Why is no real title available?)
- scientific article; zbMATH DE number 823069 (Why is no real title available?)
- scientific article; zbMATH DE number 845714 (Why is no real title available?)
- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- Inference for subgroup analysis with a structured logistic-normal mixture model
- Interaction trees with censored survival data
- Least angle regression. (With discussion)
- Model Selection and Estimation in Regression with Grouped Variables
- Performance guarantees for individualized treatment rules
- Piecewise linear regularized solution paths
- Qualitative interaction trees: a tool to identify qualitative treatment-subgroup interactions
- Random forests
- Regularization and Variable Selection Via the Elastic Net
- Regularized outcome weighted subgroup identification for differential treatment effects
- Responder identification in clinical trials with censored data
- Ridge Regression: Biased Estimation for Nonorthogonal Problems
- Sparsity and Smoothness Via the Fused Lasso
- Stability selection. With discussion and authors' reply
- Statistical modeling: The two cultures. (With comments and a rejoinder).
- Survival Trees by Goodness of Split
- The Adaptive Lasso and Its Oracle Properties
- The Bayesian Lasso
- The Elements of Statistical Learning
- Traditional multiplicity adjustment methods in clinical trials
- Tree-based methods for individualized treatment regimes
- Using decision lists to construct interpretable and parsimonious treatment regimes
Cited in
(22)- Estimation of the interpretable heterogeneous treatment effect with causal subgroup discovery in survival outcomes
- Comparing methods to assess treatment effect heterogeneity in general parametric regression models
- Overview and practical recommendations on using Shapley values for identifying predictive biomarkers via CATE modeling
- Using individualized treatment effects to assess treatment effect heterogeneity
- Explaining individualized treatment rules: integrating LIME and SHAP with XGBoost in precision medicine
- Isotonic subgroup selection
- Inference with combined data from subgroup selection and validation phases in clinical trials
- Multiplicity considerations in subgroup analysis
- Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials
- Auxiliary variable-enriched biomarker-stratified design
- Design and estimation in clinical trials with subpopulation selection
- Random forests of interaction trees for estimating individualized treatment effects in randomized trials
- Subgroup identification in dose-finding trials via model-based recursive partitioning
- A recursive partitioning approach for subgroup identification in individual patient data meta-analysis
- Regression trees with fused leaves
- Does remdesivir lower COVID-19 mortality? A subgroup analysis of hospitalized adults receiving supplemental oxygen
- Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects
- Estimating the quality of optimal treatment regimes
- Subgroup identification via multiple change point detection: methods and applications
- Impact of treatment effect heterogeneity on the estimation of individualized treatment rules for count outcomes
- Contrasting global and patient-specific regression models via a neural network representation
- Subgroup identification by supervised clustering analysis of disease outcomes and biomarkers with repeated measurements
This page was built for publication: Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q7002172)
